-
In this issue: Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.
-
-
Central line-associated infections, particularly bloodstream infections (BSI), remain a huge issue in our technological age.
-
The genomics of resistance to immunodeficiency virus (GRIV) Cohort was established in France in 1995 to generate a large database for genetic studies to identify host genes associated with rapid progression and long-term non-progression to AIDS.
-
In this study, 296 previously healthy eligible adults ages 20-64 with onset of influenza-like symptoms within the previous 48 hours and a positive rapid antigen test were enrolled in a double-blind, placebo-controlled trial conducted at Nagasaki University.
-
More women are taking a second look at the intrauterine device (IUD) for contraception. IUD insertions went up 23% between January 2008 and January 2009, according to SDI Health, a health care analytics firm in Plymouth Meeting, PA.
-
Where do male services fit in the picture when it comes to your facility? While most family planning centers report a percentage of male patients who receive sexually transmitted infection care (74%) and contraceptive care (68%), males make up only 5% nationally of their overall caseload.
-
As a reproductive health clinician, you might be looking to upcoming health care reform to make a difference in improving the status of sexual health care in the United States.
-
Results of a recent analysis of a survey of HIV care providers shows that clinicians often don't screen for genital herpes (herpes simplex virus-2 or HSV-2) in HIV-positive patients.
-
